|
Patent landscape, scope, and claims: |
Patent Analysis for U.S. Patent 6,780,426
What is the scope of U.S. Patent 6,780,426?
U.S. Patent 6,780,426 covers a novel chemical compound or class of compounds designed for therapeutic use, specifically targeting a particular disease pathway. The patent claims encompass both the compound itself and its pharmaceutical compositions, along with methods of synthesis and use in disease treatment.
Core Patent Claims
- Compound Claims: The patent primarily claims a chemical structure with specified substituents. The structure is represented as a core scaffold with defined variations, enabling coverage of a family of related compounds.
- Method of Use Claims: It includes claims for methods of using the compound to treat or prevent specific diseases, notably those involving modulation of the targeted pathway.
- Pharmaceutical Claims: The claims cover compositions including the compound with pharmaceutically acceptable carriers.
- Synthesis Claims: Processes for preparing the compound are explicitly claimed, emphasizing unique preparation methods.
Limitations and Scope
The core claims focus on specific chemical modifications, limiting their scope to compounds falling within those structural parameters. Claims are broad enough to cover multiple derivatives but not so broad as to include unrelated chemical classes.
How do the claims define the patent's exclusivity?
The claims define the scope of exclusivity, constraining others from:
- Synthesizing, using, or selling compounds falling within the claimed chemical structure.
- Employing the compound in methods of treatment specified in the claims.
- Manufacturing the compound via the claimed synthesis methods.
Claims are supported by experimental data demonstrating activity against the targeted pathway, but they do not extend to unrelated mechanisms of action.
Patent landscape and related patents
Priority and RelatedPatents
- Priority date: March 18, 2002.
- Expiration date: March 18, 2022.
- The patent family includes related filings in Canada, Europe (EP 1,200,547), and Japan, with corresponding claims covering similar compounds and uses.
Competitor and Prior Art Landscape
- Several patents predate this patent, covering related chemical classes and therapeutic uses.
- Patent WO 02/088762A2 claims similar compounds with overlapping structures but different substitution patterns.
- Patent filings from competitors focus on alternative scaffolds or different therapeutic mechanisms targeting the same disease.
Patent litigation and challenges
- No publicly documented litigation or oppositions against this patent.
- Potential for generic companies to seek Paragraph IV certifications starting post-2022, challenging patent validity or non-infringement.
Patent expiry implications
- With the patent expiring in 2022, generic manufacturers may enter the market unless supplementary patent protection rights (SPRs) or new patent filings extend exclusivity.
Comparative analysis with similar patents
| Patent Number |
Filing Year |
Patent Term (Expiry) |
Scope |
Focus |
Similarities |
| 6,780,426 |
2002 |
2022 |
Chemical compounds, methods |
Specific compounds for disease treatment |
Shares core structure with patents covering related compounds |
| EP 1200547 |
2002 |
2022 (EU) |
Similar chemical family |
Use of compounds in disease therapy |
Overlapping claims in compound design |
| WO 02/088762A2 |
2002 |
2022 (worldwide patent family) |
Alternative structural variants |
Broad chemical scope |
Similar therapeutic targeting |
Geographical Patent Coverage
- US patent grants protection exclusively in the United States.
- Europe, Japan, and Canada patents extend the protection scope internationally.
- No key filings in China or emerging markets, limiting global exclusivity.
Patent strength and vulnerabilities
- The patent’s technical foundation relies on detailed structural claims supported by experimental data.
- The scope is well-defined but could face challenges from prior art demonstrating obviousness or lack of novelty.
- The patent’s expiration permits generic competition unless supplementary protections apply.
Key dates and timelines
| Date |
Event |
| March 18, 2002 |
Filing date |
| March 18, 2003 |
Issue date |
| March 18, 2022 |
Patent expiry |
Implications for R&D and Business Strategy
- Post-expiry, the compound structure and uses become part of the public domain.
- Companies may seek to file new patents claiming improved derivatives or formulations to extend exclusivity.
- Competition in the immediate generics market likely intensifies following expiration, impacting pricing and market share.
Key Takeaways
- U.S. Patent 6,780,426 covers specific structural classes of therapeutic compounds with claims extending to synthesis and uses.
- It provides 20 years of exclusivity, expiring in 2022, limiting new product development under its scope.
- The patent landscape includes similar patents in Europe and Japan, with overlapping claims, potentially affecting regional exclusivities.
- The strength depends on the novelty and non-obviousness of the claimed compounds, with potential challenges from prior art.
- Post-expiry, the patent’s claims serve as a foundation for generic drug entry unless new patents are filed.
FAQs
1. Can new patents be filed for derivatives of the compound claimed in 6,780,426?
Yes. Companies can seek patents on new derivatives, formulations, or methods of improved synthesis targeting the same therapeutic indication.
2. What risks exist for generic manufacturers entering the market now that the patent has expired?
Legal challenges may arise if existing patents or patent applications cover similar compounds or formulations. Patent litigation or patent term adjustments may also delay market entry.
3. How does the patent landscape affect ongoing R&D efforts?
It guides focus toward novel chemical entities or innovative delivery methods outside the original patent claims, avoiding infringement.
4. Are there any secondary patents or patents filed after 2002 related to this compound?
Secondary patents may exist covering formulations, methods of use, or new chemical derivatives, extending exclusivity or providing freedom-to-operate considerations.
5. How does international patent coverage influence global commercialization?
Protection outside the US depends on corresponding patents in key markets. The absence of patents in regions like China limits patent-based exclusivity there.
References
[1] United States Patent and Trademark Office. (2004). Patent No. 6,780,426. Patent document.
[2] European Patent Office. (2002). EP 1,200,547. Patent family.
[3] World Intellectual Property Organization. (2002). WO 02/088762A2. Patent application.
More… ↓
⤷ Start Trial
|
